Mudan Lu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 11
- Cancer-related Molecular Pathways 6
- Drug Transport and Resistance Mechanisms 3
-
- FOXO transcription factor regulation 9
- Heat shock proteins research 3
- Circular RNAs in diseases 3
- RNA modifications and cancer 2
- Gut microbiota and health 2
- Co-authors
- Daozhen Chen (16 shared papers)Aiguo Shen (11 shared papers)Chun Cheng (8 shared papers)Yueming Zhao (7 shared papers)Qing-feng Pang (4 shared papers)Song He (5 shared papers)Yaxian Wu (3 shared papers)Bin-bin Wan (3 shared papers)
In The Last Decade
Mudan Lu
38 papers receiving 941 citations
Peers
Comparison fields: 5 of 98
- Cancer Research 156
- Aging 18
- Molecular Biology 522
- Geriatrics and Gerontology 19
- Immunology 117
Countries citing papers authored by Mudan Lu
This map shows the geographic impact of Mudan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mudan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mudan Lu more than expected).
Fields of papers citing papers by Mudan Lu
This network shows the impact of papers produced by Mudan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mudan Lu. The network helps show where Mudan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mudan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2009 | 69 | |
| 3 | 2009 | 59 | |
| 4 | 2015 | 54 | |
| 5 | 2008 | 52 | |
| 6 | 2009 | 49 | |
| 7 | 2019 | 44 | |
| 8 | 2019 | 39 | |
| 9 | 2009 | 38 | |
| 10 | 2020 | 37 | |
| 11 | 2012 | 35 | |
| 12 | 2019 | 30 | |
| 13 | 2020 | 27 | |
| 14 | 2012 | 25 | |
| 15 | 2016 | 24 | |
| 16 | 2008 | 22 | |
| 17 | 2019 | 21 | |
| 18 | 2015 | 20 | |
| 19 | 2018 | 18 | |
| 20 | 2016 | 17 |
About Mudan Lu
Mudan Lu is a scholar working on Oncology, Molecular Biology, Public Health, Environmental and Occupational Health, Immunology and Cancer Research, having authored 39 papers that have together received 954 indexed citations. Recurring topics across this work include FOXO transcription factor regulation (9 papers), Cancer-related Molecular Pathways (6 papers), Pregnancy and Medication Impact (3 papers), Heat shock proteins research (3 papers), Circular RNAs in diseases (3 papers), Drug Transport and Resistance Mechanisms (3 papers), RNA modifications and cancer (2 papers) and Gut microbiota and health (2 papers). The work is most often cited by research in Cancer Research (156 citations), Aging (18 citations), Molecular Biology (522 citations), Geriatrics and Gerontology (19 citations) and Immunology (117 citations). Mudan Lu has collaborated with scholars based in China, Ethiopia and Fiji. Frequent co-authors include Daozhen Chen, Aiguo Shen, Chun Cheng, Yueming Zhao, Qing-feng Pang, Song He, Yaxian Wu, Bin-bin Wan, Bo Gao and Yonghua Liu. Their work appears in journals such as Medical Oncology, International Journal of Nanomedicine, Acta Biochimica et Biophysica Sinica, International Immunopharmacology and Archives of Medical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.